OR WAIT null SECS
Growth and Advancements in Fill/Finish
Leveraging automation advancements can help improve efficiency in aseptic processing.
Changes and Trends in the Outsourcing Landscape
Quality Considerations in Changing Excipient Providers
August 03, 2023
A comprehensive understanding of what makes mRNA vaccines tick is crucial in charting the future of the market.
August 02, 2023
The industry is taking steps to automate the final product inspection process for complex therapeutics.
More than a third of CMOs are struggling to keep skilled technical and production staff.
Current good manufacturing practices for oral solid dosage forms protect the product from contamination and potential errors.
Only a significant joint effort across the supply chain will help to make healthcare more sustainable and reduce the impact of climate change on global health.
What impact will EMA’s decision to phase out COVID-19 regulatory flexibilities have on the pharma industry?
Manufacturer lawsuits prompt CMS to [slightly] modify pricing plan.
mRNA may be a modality whose chief advances are yet to come.
The more information shared, the smoother the approval process, says Susan J. Schniepp, distinguished fellow with Regulatory Compliance Associates.
Mapping America’s Pharmaceutical Supply (MAPS) Act aims to establish a database including key information about critical drugs so supply chain weaknesses can be identified.